The clinical detail is well established, and the legal position has tightened sharply in the last year
The FDA shortage designation for both GLP-1s was resolved in early 2025 tirzepatide in December 2024, semaglutide on February 21, 2025 and by May 22, 2025, large scale compounding was legally prohibited
Sarkar C, Quispe C, Jamaddar S, et al
This flexible approach helps optimize both safety and long-term outcomes
However, because metrorrhagia can be caused by various medical conditions, it can be accompanied by symptoms specific to them , such as: Loss of libido Hot flashes Dyspareunia (painful intercourse) Pelvic pain Difference between Spotting and a Period It is important not to mistake spotting between periods for an actual period